About Raspberry Pharma
Raspberry Pharma is an Industrial Goods & Manufacturing company. Pharmaceutical products and manufacturing services in India. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. Its Indian entity Raspberry Pharmaceuticals Private Limited reported revenue of βΉ26.6 Lakh. Raspberry Pharma offers products and services including BERRYXIME-200 and LICO DX SYRUP. Its focus areas include Manufacturing Services, Contract Manufacturing, Third-Party Production and Pharmaceuticals.
Company details
Raspberry Pharma is recognized as a pharmaceutical company in India that provides high-quality healthcare solutions with integrity. A distinctive product line is offered primarily to general practitioners, gynecologists, pediatricians, and specialized physicians, focusing on managing chronic and metabolic disorders, critical care, and vitamin supplements. Vertically integrated operations are maintained, including in-house formulation development, regulatory affairs, manufacturing, and quality assurance. It is noted for serving as a reliable supplier in contract manufacturing, ensuring products are delivered effectively to meet patient needs. This approach supports the delivery of specialized goods in the healthcare sector.
- SectorsIndustrial Goods & ManufacturingHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website raspberrypharma.com
- Legal Name Raspberry Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 28 Jul, 2023
- Jurisdiction Indore, Madhya Pradesh, India
- Indian entity revenue₹26.6 Lakh
FY 2025 · +132% YoY
- Indian entity net profit₹55,672
FY 2025 · 2% margin
- Indian entity EBITDA₹62,592
FY 2025 · 2% margin
Associated legal entities of Raspberry Pharma
Raspberry Pharma operates through Raspberry Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Raspberry Pharmaceuticals Private Limited CIN U46497MP2023PTC066919 | Active | 28 Jul 2023 | Indore, Madhya Pradesh | ₹0.3 Cr | 2 | View details |
Products & Services of Raspberry Pharma
Raspberry Pharma offers a comprehensive portfolio of products and services, including BERRYXIME-200 and LICO DX SYRUP.
This product is utilized for therapeutic purposes in healthcare settings.
This syrup is employed for addressing specific health needs in medical practice.
Board of directors of Raspberry Pharmaceuticals Private Limited (Raspberry Pharma)
Raspberry Pharmaceuticals Private Limited is the primary company behind Raspberry Pharma. The board of Raspberry Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Ram Kailash Dangi, appointed in 2023. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ram Kailash Dangi DIN 10258990 | Director | 28 Jul 2023 | 3 yrs 3 mo | Raspberry Pharmaceuticals Private Limited |
| Prashant Gupta DIN 10442996 | Director | 01 Dec 2025 | 11 mo | Raspberry Pharmaceuticals Private Limited |
Financials of Raspberry Pharma
Figures of Raspberry Pharmaceuticals Private Limited, the primary company behind Raspberry Pharma, for FY 2025. Revenue was ₹26.6 Lakh (+132% year on year). Net profit was ₹55,672 (2% margin). EBITDA was ₹62,592 (2% margin).
- ₹26.6 LakhRevenue · FY 2025 · +132% YoY
- ₹55,672Net profit · 2% margin
- ₹62,592EBITDA · 2% margin
- ₹2 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Raspberry Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Raspberry Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Raspberry Pharma
The primary company behind Raspberry Pharma, Raspberry Pharmaceuticals Private Limited, reported revenue of βΉ26.6 Lakh for FY 2025, up 132% year on year.
Raspberry Pharma is recognized as a pharmaceutical company in India that provides high-quality healthcare solutions with integrity. A distinctive product line is offered primarily to general practitioners, gynecologists, pediatricians, and specialized physicians, focusing on managing chronic and metabolic disorders, critical care, and vitamin supplements. Vertically integrated operations are maintained, including in-house formulation development, regulatory affairs, manufacturing, and quality assurance. It is noted for serving as a reliable supplier in contract manufacturing, ensuring products are delivered effectively to meet patient needs. This approach supports the delivery of specialized goods in the healthcare sector.
Raspberry Pharma offers BERRYXIME-200 and LICO DX SYRUP.
Raspberry Pharma operates through Raspberry Pharmaceuticals Private Limited.
The legal entities of Raspberry Pharma currently have 2 directors, including Ram Kailash Dangi, Prashant Gupta.
